These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 24460306)

  • 21. Human renal UOK130 tumor cells: a drug resistant cell line with highly selective over-expression of glutathione S-transferase-pi isozyme.
    Wang W; Liu G; Zheng J
    Eur J Pharmacol; 2007 Jul; 568(1-3):61-7. PubMed ID: 17509556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIF-1α siRNA and cisplatin in combination suppress tumor growth in a nude mice model of esophageal squamous cell carcinoma.
    Liao HY; Wang GP; Gu LJ; Huang SH; Chen XL; Li Y; Cai SW
    Asian Pac J Cancer Prev; 2012; 13(2):473-7. PubMed ID: 22524809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparison of stepwise and pulse induced cisplatin-resistant ovarian cancer cell sublines].
    Cheng G; Li Y; Tian F
    Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):305-8. PubMed ID: 11783113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Impact of RNA interference targeting hypoxia-inducible factor-1alpha on chemosensitivity in esophageal squamous cell carcinoma cells under hypoxia].
    Wu XA; Sun Y; Fan QX; Wang LX; Wang RL; Zhang L
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(37):2640-4. PubMed ID: 18162154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PRPS1 silencing reverses cisplatin resistance in human breast cancer cells.
    He M; Chao L; You YP
    Biochem Cell Biol; 2017 Jun; 95(3):385-393. PubMed ID: 28177767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of TS, DPD, ERCC1, GST-Pi, EGFR, and HER2 gene expression after neoadjuvant three-modality treatment in patients with esophageal cancer.
    Schneider S; Uchida K; Brabender J; Baldus SE; Yochim J; Danenberg KD; Salonga D; Chen P; Tsao-Wei D; Groshen S; Hoelscher AH; Schneider PM; Danenberg PV
    J Am Coll Surg; 2005 Mar; 200(3):336-44. PubMed ID: 15737843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancement of silencing DNA polymerase β on the radiotherapeutic sensitivity of human esophageal carcinoma cell lines.
    Wang Y; Chen X; Hu X; Zhang R; Du Y; Zang W; Dong Z; Zhao G
    Tumour Biol; 2014 Oct; 35(10):10067-74. PubMed ID: 25015190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Silencing of PDK1 gene expression by RNA interference suppresses growth of esophageal cancer.
    Yu J; Chen KS; Li YN; Yang J; Zhao L
    Asian Pac J Cancer Prev; 2012; 13(8):4147-51. PubMed ID: 23098536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA polymerase beta promoter mutations affect gene transcription, translation and the sensitivity of esophageal cancer cells to cisplatin treatment.
    Wang T; Zang W; Ma Y; Li M; Xuan X; Wang N; Wu R; Li Y; Dong Z; Zhao G
    Mol Biol Rep; 2013 Feb; 40(2):1333-9. PubMed ID: 23117284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Silencing of long non-coding RNA LINC01270 inhibits esophageal cancer progression and enhances chemosensitivity to 5-fluorouracil by mediating GSTP1methylation.
    Li N; Zhao Z; Miao F; Cai S; Liu P; Yu Y; Wang B
    Cancer Gene Ther; 2021 May; 28(5):471-485. PubMed ID: 33199829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Forkhead Box Protein C2 (FOXC2) Promotes the Resistance of Human Ovarian Cancer Cells to Cisplatin In Vitro and In Vivo.
    Li C; Ding H; Tian J; Wu L; Wang Y; Xing Y; Chen M
    Cell Physiol Biochem; 2016; 39(1):242-52. PubMed ID: 27336949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of Interleukin-6 suppresses cisplatin-induced cytotoxicity in esophageal squamous cell carcinoma cells.
    Suchi K; Fujiwara H; Okamura S; Okamura H; Umehara S; Todo M; Furutani A; Yoneda M; Shiozaki A; Kubota T; Ichikawa D; Okamoto K; Otsuji E
    Anticancer Res; 2011 Jan; 31(1):67-75. PubMed ID: 21273582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone marrow-derived mesenchymal stem cells increase drug resistance in CD133-expressing gastric cancer cells by regulating the PI3K/AKT pathway.
    Ji N; Yu JW; Ni XC; Wu JG; Wang SL; Jiang BJ
    Tumour Biol; 2016 Nov; 37(11):14637-14651. PubMed ID: 27619680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The modifier subunit of glutamate cysteine ligase relates to cisplatin resistance in human small cell lung cancer xenografts in vivo.
    Nishi M; Abe Y; Fujimori S; Hamamoto A; Inoue Y; Miyazaki N; Oida Y; Ikoma N; Ohnishi Y; Yamazaki H; Ueyama Y; Nakamura M
    Oncol Rep; 2005 Aug; 14(2):421-4. PubMed ID: 16012725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of vinorelbine on cisplatin resistance reversal in human lung cancer A549/DDP cells.
    Zhou YT; Li K; Tian H
    Asian Pac J Cancer Prev; 2013; 14(8):4635-9. PubMed ID: 24083716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LncRNA PCAT-1 promotes tumour growth and chemoresistance of oesophageal cancer to cisplatin.
    Zhen Q; Gao LN; Wang RF; Chu WW; Zhang YX; Zhao XJ; Lv BL; Liu JB
    Cell Biochem Funct; 2018 Jan; 36(1):27-33. PubMed ID: 29314203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD.
    Chen Y; Ke G; Han D; Liang S; Yang G; Wu X
    Exp Cell Res; 2014 Jan; 320(1):12-20. PubMed ID: 24183997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. α-solanine enhances the chemosensitivity of esophageal cancer cells by inducing microRNA‑138 expression.
    Wu J; Wang L; Du X; Sun Q; Wang Y; Li M; Zang W; Liu K; Zhao G
    Oncol Rep; 2018 Mar; 39(3):1163-1172. PubMed ID: 29328459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of chemoresistance mechanisms in a series of cisplatin-resistant transitional carcinoma cell lines.
    Hour TC; Chen J; Huang CY; Guan JY; Lu SH; Hsieh CY; Pu YS
    Anticancer Res; 2000; 20(5A):3221-5. PubMed ID: 11062746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Construction and application of a lung cancer stem cell model: antitumor drug screening and molecular mechanism of the inhibitory effects of sanguinarine.
    Yang J; Fang Z; Wu J; Yin X; Fang Y; Zhao F; Zhu S; Li Y
    Tumour Biol; 2016 Oct; 37(10):13871-13883. PubMed ID: 27485114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.